Clinical trial
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Adapalene Gel 0.3% to Differin® (Adapalene Gel 0.3%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
NCT02411942 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Adapalene Gel 0.3% to Differin® (Adapalene Gel 0.3%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- February 28, 2015
- Enrollment
- 753 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.